Details for: LANVIS
Company: ASPEN PHARMACARE CANADA INC.
DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
---|---|---|---|---|---|
00282081 | LANVIS | THIOGUANINE | 40 MG | TABLET | ORAL |
Summary Reports
Consumer Information
This information was provided by the drug’s manufacturer when this drug product was approved for sale in Canada. It is designed for consumers and care givers. It is a summary of information about the drug and will not tell you everything about the drug. Contact your doctor or pharmacist if you have any questions about the drug.
What the medication is used for
LANVIS®
is used to treat acute leukemia. This is a cancer of the blood and bone marrow.
LANVIS® will not be given to you as treatment to help prevent your cancer from coming back
after it had disappeared. It will also not be given as a long-term treatment.
What it does
LANVIS® works by reducing the number of new blood cells your body makes.
When it should not be used
Do not use LANVIS® if:
- your disease has previously stopped responding to LANVIS® or to treatment with another drug called PURINETHOL. The active ingredient in this drug is mercaptopurine. you are allergic to thioguanine or any of the other ingredients in this medicine, including any non-medicinal ingredient or component of the container.
What the medicinal ingredient is
thioguanine
What the non-medicinal ingredients are
gum acacia, lactose, magnesium stearate, potato starch and stearic acid
What dosage form it comes in
Tablets, 40 mg
Warnings and precautions
Serious Warnings and Precautions
LANVIS®
is a cytotoxic agent. This means it kills cells in your body including cancer cells.
LANVIS® must only be given to you by a healthcare professional experienced in the use of
drugs to treat cancer.
Side effects of LANVIS® can include:
Bone marrow suppression (neutropenia, thrombocytopenia or anemia): Lanvis® can
affect your bone marrow’s ability to make blood cells. It can cause you to have low blood cell
counts and platelets. This can cause life-threatening infections and bleeding and is especially
dangerous if your body does not make enough of the enzyme, thiopurine methyltransferase
(TPMT).
-
Neutropenia is a low white blood cell count.
Thrombocytopenia is low platelets in the blood.
Anemia is a low red blood cell count.
Severe infection following immunization with a live vaccine. You should not receive a live vaccine when you are taking LANVIS® .
To help avoid side effects and ensure proper use, talk to your healthcare professional before you take LANVIS® . Talk about any health conditions or problems you may have, including if you:
- are pregnant, or you are planning a pregnancy;
Females who are pregnant or plan to become pregnant: - LANVIS® may harm your unborn baby.
- Avoid becoming pregnant while you are taking LANVIS® .
- Use effective methods of birth control while you are taking LANVIS® . Talk to your healthcare professional about methods of birth control that may be right for you.
- If you do become pregnant while taking LANVIS® , stop using it and tell your healthcare professional right away.
- are breastfeeding or are planning to breastfeed. It is not known if LANVIS® passes into breast milk. You and your doctor should discuss whether you will take LANVIS® or breastfeed. You should not do both. Talk to your doctor about ways to feed your baby while you are taking LANVIS® .
- plan to father a child. Your partner should not become pregnant while you are using LANVIS® . You should use birth control to prevent pregnancy in your partner during your treatment. If your partner becomes pregnant while you are receiving LANVIS® , tell your healthcare professional right away.
- you have been vaccinated, or are planning to be vaccinated, with a live vaccine.
- Your body does not make enough of (you are deficient in) the enzyme called thiopurine methyltransferase (TPMT). If you do not have enough of this enzyme, you may get serious side effects if you use LANVIS® .
- you have kidney problems;
- you have liver problems;
- you have a mutation in your NUDT15 gene. If you have this mutation, you may be more likely to develop low levels of white cells in your blood. This may cause you to get infections. The mutation may also put you at a higher risk of losing your hair. Patients of Asian descent may be particularly at risk.
- You are going to be exposed to sunlight, sun lamps or tanning beds. Your treatment with LANVIS® may make you more sensitive to sun and ultraviolet (UV) light. Limit your exposure to the sun and to UV light while you are taking LANVIS® . Be sure to also wear protective clothing and use sunscreen with a high protection factor (spf).
Intestinal necrosis and perforation can occur with LANVIS® use.
- Intestinal necrosis is a condition that occurs when there is low blood flow to the intestines.
- Intestinal perforation is when a hole forms in the wall of the intestine.
- These are serious and potentially life-threatening side effects of LANVIS® use. If you experience bloating or swelling in the abdomen, bloody stools, diarrhea severe abdominal pain and vomiting, call your healthcare professional right away. These may be signs that you are experiencing intestinal necrosis or a perforation.
As LANVIS® use may cause low white blood cells, low red blood cells and low platelets, you may be at increased risk of infection, bleeding and bruising, be sure to:
- Wash your hands often.
- Keep your mouth and skin clean and healthy.
- Avoid people who are sick.
- Try not to bump into things or cut yourself.
- Blow your nose gently.
- Avoid getting constipated.
- Brush your teeth gently with a soft toothbrush.
- Avoid products containing aspirin or ibuprofen.
- Rest if you need to.
- Call your doctor if you have a fever or other flu-like symptoms or if you have any bleeding, bruising, fatigue, tiny red spots on the skin or weakness.
Thioguanine, the medicinal ingredient in LANVIS® , may cause cancer or damage to the genetic material in cells (DNA). Talk to your healthcare professional if you have questions about this.
Driving and operating machines:
Before you do tasks that require special attention, wait until you know how you respond to LANVIS® treatment.
Blood tests:
Your doctor will ask you to have blood tests done before you take LANVIS® for the first time. Some of these tests will be repeated every week and others will be repeated every month while you are taking LANVIS® . This is to check your blood cell counts and to monitor how well your liver is working.
Your doctor may also perform genetic testing before or during your treatment. These tests will determine if you have the NUDT15 gene mutation and if you are deficient in the enzyme, TPMT. The results of these tests will help your doctor to know if your response to LANVIS® may be affected by your genetics. Your doctor may change your dose of LANVIS® after these tests.
Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.
Interactions with this medication
Serious Drug Interactions
- Vaccines containing live viruses. There is a risk for serious infections if these are given with LANVIS® .
- Other cytotoxic drugs or radiation therapy. The risk for bone marrow suppression is increased when these are used with LANVIS® .
- Olsalazine, mesalazine or sulphasalazine. These are medicines that prevent inflammation and are used in the treatment of inflammatory bowel disease.
The following may also interact with LANVIS® :
- Busulfan. This is a medicine used to treat a type of cancer.
Proper use of this medication
How to take LANVIS®:
- Take this medicine exactly as your healthcare professional has told you to.
- Take it once per day by mouth.
- Check with your healthcare professional if you are not sure how to take it.
- Your healthcare professional will tell you how much LANVIS® to take and when to take it.
Usual Dose
Usual starting dose: 2 mg / kg of body weight
If, after one month of treatment, your condition has not improved, your dose may be increased
to 3 mg / kg of body weight.
The amount of LANVIS® you will take will depend on your weight and how you respond to
treatment.
Your healthcare professional may interrupt or stop your treatment, or reduce your dose of
LANVIS®
. This will depend on how you are feeling or if your disease has gotten worse.
Overdose
Missed Dose
- If you miss a dose of LANVIS® , take it as soon as possible.
- If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule as prescribed by your doctor.
- Never take two doses at the same time to make up for a missed dose.
- If you miss two doses of LANVIS® , contact your doctor.
Side effects and what to do about them
These are not all the possible side effects you may feel when taking LANVIS®
. If you
experience any side effects not listed here, contact your healthcare professional.
Side effects may include:
- loss of appetite
- increased sensitivity to sun exposure
Symptom / effect | Talk with your doctor, nurse, or pharmacist only if severe | Talk with your doctor, nurse, or pharmacist in all cases | Stop taking drug and get immediate medical help |
---|---|---|---|
Very Common | |||
Neutropenia (decreased white blood cells): aches, feeling tired, fever, flu-like symptoms, any signs of infections (sore throat, sore mouth or urinary problems) | ✘ | ||
Thrombocytopenia (decreased platelets in the blood): bruising, fatigue, tiny red dots on the skin, weakness. | ✘ | ||
Anemia (decreased red blood cells): dizziness, feeling tired and weak, loss of energy, shortness of breath. | ✘ | ||
Liver damage: abdominal pain, dark urine, fatigue, itching, loss of appetite, nausea, rash, swelling in the abdomen, vomiting, weight loss, yellowing of the skin or eyes (jaundice). | ✘ | ||
Common | |||
Veno-occlusive disease (a condition where liver veins are blocked): enlargement of liver which causes abdomen to swell and fluid to accumulate there, yellowing of the skin or eyes (jaundice), vomiting of blood. | ✘ | ||
Nausea | ✘ | ||
Vomiting | ✘ | ||
Diarrhea (loose or watery and frequent stools) | ✘ | ||
Stomatitis (mouth sores and swelling): burning sensation and pain in the mouth, difficulty eating, swelling, sores or ulcers in the mouth. | ✘ | ||
Esophageal varices (swollen veins in the lower section of the esophagus that can bleed): vomiting blood, black or bloody stools, lightheadedness and loss of consciousness in severe cases. | ✘ | ||
Hyperuricemia (high level of uric acid in the blood): fever, pain in a joint, swelling of a joint, or kidney problems. | ✘ | ||
Rare | |||
Intestinal necrosis or perforation (potentially life threatening conditions where intestines are damaged): bloating or swelling in the abdomen, bloody stools, diarrhea (loose or watery and frequent stools), severe abdominal pain, vomiting. | ✘ | ||
Severe liver damage: confusion, disorientation, coma, pain in upper right side of the abdomen, sleepiness, yellowing of the skin or eyes (jaundice). | ✘ |
If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, talk to your healthcare professional.
How to store
Store LANVIS®
in a dry place between 15° and 25°C. Protect it from light.
LANVIS®
is cytotoxic. Be careful not to contaminate your hands or inhale the drug when you
are handling LANVIS®
.
Return unused tablets to your healthcare professional. Be cautious when you are packaging
your leftover LANVIS®
for transportation.
Keep out of reach and sight of children.
Reporting side effects
You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following three ways:
- Report online at www.healthcanada.gc.ca/medeffect
- Call toll-free at 1-866-234-2345
- Complete a Canada Vigilance Reporting Form and:
- Fax toll-free to 1-866-678-6789, or
- Mail to:
Canada Vigilance Program
Health Canada
Postal Locator 0701E
Ottawa ON K1A 0K9
Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at www.healthcanada.gc.ca/medeffect.
NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.
More information
If you want more information about LANVIS®:
- Talk to your healthcare professional
- Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website ( https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html) or the Aspen Pharmacare Canada Inc. website (www.aspenpharma.ca.), or by calling 1-844-330-1213.
Aspen Pharmacare Canada Inc.
111 Queen Street East, Suite 450
Toronto, Ontario M5C 1S2
Date of Revision: April 5, 2019
® LANVIS is registered trademark of Aspen. All rights reserved.